# Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis

> **NCT02341417** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 28 (actual)

## Conditions studied

- Secondary Hyperparathyroidism, Chronic Kidney Disease

## Interventions

- **DRUG:** Cinacalcet

## Key facts

- **NCT ID:** NCT02341417
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-10
- **Primary completion:** 2017-03-15
- **Final completion:** 2017-03-15
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02341417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02341417, "Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02341417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*